Last year, MaxCyte Inc generated 18.69M USD for its biggest-performing segment, Product sales. The Inside the United States made the largest contribution, accounting for 21.08M USD last year. For the latest quarter, MaxCyte Inc reported the revenue of 4.10M USD for the period ending 2026-06-30, which came from the top-performing segment, Product sales. Inside the United States contributed the highest revenue, at 4.63M USD.

By Business

Revenue

Proportion

Annual

Annual

Quarterly

Product sales

Product

Licenses

other

FY2025

FY2024

Product sales

18.69M(36.14%)

21.09M(35.32%)

Product

18.69M(36.14%)

21.09M(35.32%)

Licenses

12.37M(23.92%)

16.41M(27.48%)

other

1.97M(3.80%)

1.13M(1.89%)

By Region

Revenue

Proportion

Annual

Annual

Quarterly

Inside the United States

Outside the United States

FY2025

FY2024

Inside the United States

21.08M(63.82%)

25.77M(66.71%)

Outside the United States

11.95M(36.18%)

12.86M(33.29%)